Brief: Portage Biotech Plans To Expand Its Evaluation Of Strategic Alternatives
12/04/2024 15:21
April 12 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH ANNOUNCES PLANS TO EXPAND ITS EVALUATION
OF
STRATEGIC ALTERNATIVES
* PORTAGE BIOTECH INC - BOARD OF DIRECTORS HAS MADE
DECISION TO
PAUSE FURTHER ENROLLMENT IN ADPORT-601 CLINICAL TRIAL OF PORT-6
AND PORT-7
* PORTAGE BIOTECH INC: WILL EXPLORE STRATEGIC ALTERNATIVES
* PORTAGE BIOTECH INC: IF COMPANY IS UNABLE TO COMPLETE A
TRANSACTION, IT MAY BE REQUIRED TO SEEK A RESTRUCTURING OR
COMPANY WIND DOWN
Source text for Eikon: ID:nGNX4Zmwvl
Further company coverage: PRTG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpha Compute
See all newsBrief: Alpha Compute Corp. Provides Mid-Q2 2026 Update
Brief: Alpha Compute Ai Gpu Launch Update First Large-Scale Nvidia Blackwell Cluster
Brief: Alpha Compute Appoints Tom Richer To Advisory Board To Accelerate Ai Gpu Compute Infrastructure And Confidential Cloud Strategy
Brief: Alphaton Capital Rebrands As Alpha Compute Corp. To Reflect Its Growing Ai Compute Business
Brief: Alphaton Capital Announces $43 Million Ai Infrastructure And Financing Partnership With Vertical Data